TableS5 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma

TableS5 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma

<p>Sequence Data Information in Lipo863B</p>

Uloženo v:

Podrobná bibliografie
Hlavní autor:	Tingting Liu (15386915) (author)
Další autoři:	Juan Wang (15386918) (author), Hongbo Yang (15386921) (author), Qiushi Jin (15386924) (author), Xiaotao Wang (15386927) (author), Yihao Fu (15386930) (author), Yu Luan (15386933) (author), Qixuan Wang (15386936) (author), Mark W. Youngblood (15386939) (author), Xinyan Lu (15386942) (author), Lucia Casadei (15386945) (author), Raphael Pollock (15386948) (author), Feng Yue (10656164) (author)
Vydáno:	2025
Témata:	Cancer Cancer Risk Factors Molecular and Cellular Biology DNA Damage and Repair Chromosomal translocations Gene amplification Epigenetics Chromatin structure and function Gene Regulation Mechanisms of transcription Promoter/enhancer analysis Sarcomas Soft-tissue sarcoma
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky

TableS1 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
Autor: Tingting Liu (15386915)
Vydáno: (2025)

TableS2 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
Autor: Tingting Liu (15386915)
Vydáno: (2025)

TableS3 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
Autor: Tingting Liu (15386915)
Vydáno: (2025)

TableS4 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
Autor: Tingting Liu (15386915)
Vydáno: (2025)

Supplementary Tables from Targeting BCL6 in Gastrointestinal Stromal Tumor Promotes p53-Mediated Apoptosis to Enhance the Antitumor Activity of Imatinib
Autor: Xiangyu Zeng (17314920)
Vydáno: (2025)

Supplementary Figure 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Autor: Tom Wei-Wu Chen (15053003)
Vydáno: (2025)

Supplementary Figure 2 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Autor: Tom Wei-Wu Chen (15053003)
Vydáno: (2025)

Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Autor: Tom Wei-Wu Chen (15053003)
Vydáno: (2025)

Supplementary Figure 4 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Autor: Tom Wei-Wu Chen (15053003)
Vydáno: (2025)

Supplementary Table 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Autor: Tom Wei-Wu Chen (15053003)
Vydáno: (2025)

Supplementary File 1 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
Autor: Michael P. Ludwig (16721187)
Vydáno: (2025)

Supplementary File 2 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
Autor: Michael P. Ludwig (16721187)
Vydáno: (2025)

Supplementary File 3 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
Autor: Michael P. Ludwig (16721187)
Vydáno: (2025)

Supplementary File 4 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
Autor: Michael P. Ludwig (16721187)
Vydáno: (2025)

Supplementary File 5 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
Autor: Michael P. Ludwig (16721187)
Vydáno: (2025)

Supplementary File 6 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
Autor: Michael P. Ludwig (16721187)
Vydáno: (2025)

Supplementary File 7 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
Autor: Michael P. Ludwig (16721187)
Vydáno: (2025)

Supplementary File 8 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
Autor: Michael P. Ludwig (16721187)
Vydáno: (2025)

Supplementary Tables S1-S5 from Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era
Autor: Josephine K. Dermawan (17079555)
Vydáno: (2025)

Supplementary Table S3 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma
Autor: Caleb N. Seavey (15056489)
Vydáno: (2025)

Supplementary Table S4 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma
Autor: Caleb N. Seavey (15056489)
Vydáno: (2025)

Figure 1 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Autor: David Milewski (15050643)
Vydáno: (2025)

Figure 2 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Autor: David Milewski (15050643)
Vydáno: (2025)

Figure 3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Autor: David Milewski (15050643)
Vydáno: (2025)

Figure 4 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Autor: David Milewski (15050643)
Vydáno: (2025)

Figure 5 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Autor: David Milewski (15050643)
Vydáno: (2025)

Figure 6 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Autor: David Milewski (15050643)
Vydáno: (2025)

Supplementary Table S1-S3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Autor: David Milewski (15050643)
Vydáno: (2025)

Figure S1 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Autor: Upendra Kumar Soni (15051683)
Vydáno: (2025)

Figure S2 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Autor: Upendra Kumar Soni (15051683)
Vydáno: (2025)

Figure S3 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Autor: Upendra Kumar Soni (15051683)
Vydáno: (2025)

Figure S4 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Autor: Upendra Kumar Soni (15051683)
Vydáno: (2025)

Figure S5 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Autor: Upendra Kumar Soni (15051683)
Vydáno: (2025)

Figure S6 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Autor: Upendra Kumar Soni (15051683)
Vydáno: (2025)

Supplementary Data File S1 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Autor: Upendra Kumar Soni (15051683)
Vydáno: (2025)

Supplementary Data 1 from Monitoring Sarcoma Response to Immune Checkpoint Inhibition and Local Cryotherapy with Circulating Tumor DNA Analysis
Autor: Nam Q. Bui (14958210)
Vydáno: (2025)

Supplementary Dataset S1 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
Autor: Srivandana Akshintala (16610490)
Vydáno: (2025)

Supplementary Table S5 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
Autor: Srivandana Akshintala (16610490)
Vydáno: (2025)

Video 1_Imaging-driven diagnosis of retroperitoneal psoas major alveolar soft part sarcoma: a case report.mp4
Autor: Shasha Wei (1555588)
Vydáno: (2025)

Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Autor: Man Xu (14963249)
Vydáno: (2025)

Cannot write session to /tmp/vufind_sessions/sess_06a9mjlod6pc4fp56ognei0n1n